- ClinSpec Diagnostics, a Glasgow, Scotland-based early cancer detection company, raised £2.4m in funding
- The round was led by Mercia’s EIS Funds with Scottish Investment Bank
- The company intends to use the funds to progress its multi-cancer development program
- They also plan to hire a further five employees to strengthen the scientific and operations teams, taking its total headcount to fourteen
- The company established in 2016, they have conducted studies on brain, prostate and pancreatic cancers
- The company remains open for a further £1 million to accelerate development, build value and prepare the groundwork for Series A funding
